| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |